Avanos Medical, Inc. Announces Third Quarter 2024 Results, retirement of CEO

Go back to Avanos Medical, Inc. Announces Third Quarter 2024 Results, retirement of CEO

Avanos Medical (AVNS) PT Lowered to $20 at Stifel

October 30, 2024 3:10 PM EDT

Stifel analyst Rick Wise lowered the price target on Avanos Medical (NYSE: AVNS) to $20.00 (from $24.00) while maintaining a Hold rating.

The analyst comments "This morning, Avanos announced the retirement of CEO Joe Woody and simultaneously announced the appointment of Michael Greiner to... More